References
- Hedegaard H, Chen L-H, Warner M. Drug-poisoning Deaths Involving Heroin: United States, 2000–2013. NCHS data brief, no 190. http://www.cdc.gov/nchs/data/databriefs/db190.pdf. Published 2015. Accessed April 28, 2015.
- Centers for Disease Control and Prevention. Death from Prescription Opioid Overdose. In: Injury Prevention & Control: Prescription Drug Overdose. http://www.cdc.gov/drugoverdose/data/overdose.html. Published 2015. Accessed September 23, 2015.
- Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2014.
- National Institute on Drug Abuse. Monitoring the Future Study: Trends in Prevalence of Various Drugs. In: Monitoring the Future. http://www.drugabuse.gov/trends-statistics/monitoring-future/monitoring-future-study-trends-in-prevalence-various-drugs. Published 2015. Accessed September 23, 2015.
- The American Academy of Pain Medicine. AAPM Facts and Figures on Pain. In: Gets the Facts on Pain. http://www.painmed.org/patientcenter/facts-on-pain/. Accessed Published 2013. August 22, 2013.
- Substance Abuse and Mental Health Services Administration–Health Resources Services Administration (SAMHSA-HRSA) Center for Integrated Health Solutions. Screening Tools. http://store.samhsa.gov/product/Opioid-Overdose-Prevention-Toolkit-Updated-2014/SMA14-4742. Published 2014. Accessed May 6, 2015.
- Centers for Disease Control and Prevention. Policy Impact: Prescription Painkiller Overdoses. In: Injury Prevention & Control. http://www.cdc.gov/homeandrecreationalsafety/rxbrief/. Published 2013. Accessed August 9, 2013.
- Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part I—evidence assessment. Pain Physician. 2012;15(3 Suppl):S1–S65.
- Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015;162:276–286.
- Reuben DB, Alvanzo AA, Ashikaga T, et al. National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain. Ann Intern Med. 2015;162:295–300.
- Gupta S, Atcheson R. Opioid and chronic non-cancer pain. J Anaesthesiol Clin Pharmacol. 2013;29:6–12.
- Hassett AL, Aquino JK, Ilgen MA. The risk of suicide mortality in chronic pain patients. Curr Pain Headache Rep. 2014;18:436.
- New Mexico Department of Health. Overview of Opioid Risk. In: Opioid Safety. http://nmhealth.org/publication/view/general/275/. Published 2011. Accessed August 9, 2013.
- New Mexico Department of Health. Prescription Drug Misuse and Overdose Prevention and Pain Management Advisory Council. Update on Drug Overdose and Prescribing Behavior: A Look at Death and PMP Data. Santa Fe, NM: Department of Health, State of New Mexico; 2013.
- New Mexico Department of Health. Decrease in Drug Overdose Death Rate in New Mexico. http://nmhealth.org/news/information/2014/9/?view=130. Published 2014. Accessed April 28, 2015.
- Albert S, Brason FW, Sanford CK, Dasgupta N, Graham J, Lovette B. Project Lazarus: community-based overdose prevention in rural North Carolina. Pain Med. 2011;12(Suppl 2):S77–S85.
- Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.
- Ohio Department of Health. Project DAWN (Deaths Avoided with Naloxone). In: Healthy Ohio. http://www.healthyohioprogram.org/vipp/drug/ProjectDAWN.aspx. Published 2013. Accessed August 19, 2013.
- Chou R, Fanciullo GJ, Fine PG, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10:113–130.
- Kahan M, Mailis-Gagnon A, Tunks E. Canadian guideline for safe and effective use of opioids for chronic non-cancer pain: implications for pain physicians. Pain Res Manag. 2011;16:157–158.
- Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part 2—guidance. Pain Physician. 2012;15(3 Suppl):S67–S116.
- Fishbain DA, Cole B, Lewis J, Rosomoff HL, Rosomoff RS. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review. Pain Med. 2008;9:444–459.
- Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the Current Opioid Misuse Measure. Pain. 2007;130:144–156.
- Current Opioid Misuse Measure (COMM)™. Opioid Risk Management. http://www.painedu.org/load_doc.asp?file=COMM17SFB.pdf. Published 2008. Accessed May 8, 2015.
- McAuley D. Advanced Opioid Converter. http://www.globalrph.com/opioidconverter2.htm. Published 2015. Accessed May 8, 2015.
- Amphastar Pharmaceuticals I. Naloxone. In: Products. http://www.amphastar.com/products.htm. Published 2013. Accessed August 19, 2013.
- LMA North America I. LMA MAD Nasal. http://www.lmana.com/pwpcontrol.php?pwpID=6359. Published 2011. Accessed July 31, 2013.
- National Institute of Neurological Disorders and Stroke. NINDS Common Data Elements Harmonizing Information. Streaming Research. http://www.commondataelements.ninds.nih.gov/general.aspx#tab=Data_Standards. Published 2013. Accessed September 4, 2013.
- American Medical Association. AMA Statement on Naloxone Product Approval. In: AMA News Room. https://apps.ama-assn.org/contactus/contactusMain.do. Published 2014. Accessed February 11, 2016.
- Centers for Disease Control and Prevention. Opioid overdose prevention programs providing naloxone to laypersons—United States, 2014. MMWR Morb Mortal Wkly Rep. 2015; 64(23);631–635. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6423a2.htm. Accessed February 11, 2016.
- Substance Abuse and Mental Health Services Administration (SAMHSA). Naloxone. In: Medication and Counseling Treatment. http://www.samhsa.gov/medication-assisted-treatment/treatment/naloxone. Published 2014. Accessed February 11, 2016.
- American Academy of Pain Management. Co-Prescribing of Naloxone in Conjugation with Opioid Therapy. http://blog.aapainmanage.org/co-prescribing-of-naloxone-in-conjunction-with-opioid-therapy/. Published 2016. Accessed February 12, 2016.
- White House Press Office. Presidential Memorandum—Addressing Prescription Drug Abuse and Heroine Use. In: Presidential Actions. https://www.whitehouse.gov/the-press-office/2015/10/21/presidential-memorandum-addressing-prescription-drug-abuse-and-heroin. Published 2015. Accessed February 11, 2016.
- New Mexico Department of Health. New Mexico Clinical Guidelines on Prescribing Opioids for Treatment of Pain. Santa Fe, NM: New Mexico Department of Health; 2011.
- Kolodny A, Franklin G, Gelfand S, et al. Cautions, Evidenced-Based Opioid Prescribing. 2014. http://www.supportprop.org/wp-content/uploads/2014/01/PROP_OpioidPrescribing.pdf